Mesure de la dose délivrée hors champ à l’utérus lors d’un traitement ORL par protons
Jennifer Le Guévelou(Inserm), Juliette Thariat, F. Trompier(Institut de Radioprotection et de Sûreté Nucléaire), C. Villagrasa(Treatment Action Group), A. Véla(Centre François Baclesse), A. Isambert(Institut de Radioprotection et de Sûreté Nucléaire), J. Hérault(Centre Antoine Lacassagne)
Cited by 5
Related Papers
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement
|International Journal of Radiation Oncology*Biology*Physics|2020|211
BiodosEPR-2006 Meeting: Acute dosimetry consensus committee recommendations on biodosimetry applications in events involving uses of radiation by terrorists and radiation accidents
|Radiation Measurements|2007|133
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus
|Radiotherapy and Oncology|2022|98
A New Standard DNA Damage (SDD) Data Format
|Radiation Research|2018|76
Proton therapy for locally advanced breast cancer: A systematic review of the literature
|Cancer Treatment Reviews|2017|60